Daniel J Weiss Selected Research

Lung Diseases (Lung Disease)

1/2022	Stem cells, cell therapies, and bioengineering in lung biology and disease 2021.
1/2022	Proceedings of the ISCT scientific signature series symposium, "Advances in cell and gene therapies for lung diseases and critical illnesses": International Society for Cell & Gene Therapy, Burlington VT, US, July 16, 2021.
5/2021	Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.
1/2021	Endoscopic atomization of mesenchymal stromal cells: in vitro study for local cell therapy of the lungs.
1/2021	Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution.
1/2021	Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases.
1/2021	The Coronavirus Pandemic: A Pitfall or a Fast Track for Validating Cell Therapy Products?
1/2021	Mitochondria in Focus: From Function to Therapeutic Strategies in Chronic Lung Diseases.
12/2020	Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cells.
10/2020	Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel J Weiss Research Topics

Disease

32	Lung Diseases (Lung Disease) 01/2022 - 12/2003
14	Malaria 11/2021 - 05/2014
10	Pneumonia (Pneumonitis) 01/2022 - 05/2007
10	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 12/2003
9	Inflammation (Inflammations) 01/2019 - 07/2002
8	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2021 - 09/2010
7	COVID-19 01/2022 - 01/2020
7	Lung Injury 01/2022 - 10/2005
7	Asthma (Bronchial Asthma) 06/2020 - 01/2013
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2020 - 09/2010
5	Chronic Obstructive Pulmonary Disease (COPD) 05/2021 - 09/2010
4	Wounds and Injuries (Trauma) 02/2022 - 04/2013
4	Sepsis (Septicemia) 01/2022 - 02/2014
4	Fibrosis (Cirrhosis) 10/2020 - 03/2007
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 01/2018
3	Acute Lung Injury 01/2022 - 10/2005
3	Virus Diseases (Viral Diseases) 01/2022 - 12/2003
3	Emphysema 01/2021 - 10/2014
3	Infections 01/2019 - 01/2015
3	Fever (Fevers) 01/2017 - 11/2015
3	Neoplasms (Cancer) 07/2016 - 07/2011
2	Critical Illness (Critically Ill) 01/2022 - 01/2021
2	Necrosis 01/2022 - 01/2019
2	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2018
2	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2020 - 01/2017
2	Edema (Dropsy) 01/2019 - 01/2019
2	Pulmonary Emphysema 01/2017 - 09/2010
2	Pulmonary Hypertension 10/2014 - 09/2010
2	Respiratory Hypersensitivity 02/2014 - 01/2013
2	Mesothelioma 07/2011 - 03/2007
1	Craniocerebral Trauma (Head Injury) 02/2022
1	red meat allergy 01/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Coronavirus Infections 01/2021
1	Silicosis 10/2020
1	Pneumoconiosis 10/2020
1	Granuloma 10/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2019
1	Heart Failure 12/2019
1	Diphtheria 05/2019
1	Tetanus 05/2019
1	Whooping Cough (Pertussis) 05/2019
1	Hyperplasia 01/2019

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 07/2021 - 05/2007
6	Therapeutic UsesIBA 01/2022 - 01/2018
5	InsecticidesIBA 11/2021 - 12/2015
5	Antimalarials (Antimalarial Agents)IBA 01/2021 - 11/2015
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2012
4	Indicators and Reagents (Reagents)IBA 10/2020 - 01/2016
4	OvalbuminIBA 01/2017 - 07/2011
4	AntigensIBA 11/2015 - 07/2011
3	CollagenIBA 10/2020 - 01/2019
2	EndotoxinsIBA 01/2022 - 10/2005
2	VaccinesIBA 05/2021 - 12/2019
2	C-Reactive ProteinIBA 05/2021 - 01/2017
2	SolutionsIBA 01/2021 - 01/2017
2	Pancreatic Elastase (Elastase)IBA 01/2021 - 10/2014
2	Chemotactic FactorsIBA 01/2021 - 01/2019
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2019
2	artemisinin (artemisinine)IBA 10/2020 - 01/2017
2	Pharmaceutical PreparationsIBA 10/2020 - 03/2007
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2013
2	Biological ProductsIBA 01/2018 - 05/2014
1	Warfarin (Coumadin)FDA LinkGeneric 02/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2022
1	Clopidogrel (Plavix)FDA Link 02/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2022
1	AnticoagulantsIBA 02/2022
1	LipopolysaccharidesIBA 01/2022
1	Heparitin Sulfate (Heparan Sulfate)IBA 05/2021
1	Glycoproteins (Glycoprotein)IBA 05/2021
1	remestemcel-lIBA 05/2021
1	AntibodiesIBA 01/2021
1	AlginatesIBA 01/2021
1	Biocompatible Materials (Biomaterials)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	GelatinIBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	Oxidants (Oxidizing Agents)IBA 01/2021
1	HydrogelsIBA 01/2021
1	Fibroblast Growth Factor 7 FDA Link 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	methylamphotericin B (AME)IBA 10/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2020
1	Essential DrugsIBA 06/2020
1	Naphazoline (All Clear)FDA LinkGeneric 12/2019
1	Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA 05/2019
1	Eicosapentaenoic AcidIBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Technetium (Technetium 99m)IBA 01/2019

Therapy/Procedure

41	Therapeutics 01/2022 - 01/2005
14	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2021 - 06/2009
5	Lung Transplantation 01/2019 - 05/2007
2	Punctures 01/2021 - 01/2019
2	Immunomodulation 10/2020 - 02/2016
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2008 - 01/2008
1	Blood Transfusion (Blood Transfusions) 02/2022
1	Ligation 01/2021
1	Critical Care (Surgical Intensive Care) 11/2020
1	Palliative Care (Palliative Therapy) 12/2019